Erratum: Inhibition of histone H3K9 methyltransferases by gliotoxin and related epipolythiodioxopiperazines (Journal of Antibiotics (2012) 65 (263-265) DOI: 10.1038/ja.2012.6);Inhibition of histone H3K9 methyltransferases by gliotoxin and related epipolythiodioxopiperazines

Journal of Antibiotics

Volumn 65, Issue 5, 2012, Pages 263-265

  Takahashi, Masanari ^a,b   Takemoto, Yasushi ^a   Shimazu, Tadahiro ^a   Kawasaki, Hisashi ^b   Tachibana, Makoto ^c   Shinkai, Yoichi ^a,c   Takagi, Motoki ^d   Shin Ya, Kazuo ^e   Igarashi, Yasuhiro ^f   Ito, Akihiro ^a,g   Yoshida, Minoru ^a,g  

^a RIKEN   (Japan)

^b TOKYO DENKI UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d Japan Biological Informatics Consortium   (Japan)

^e NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^f TOYAMA PREFECTURAL UNIVERSITY   (Japan)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

epipolythiodioxopiperazine (ETP); G9a; gliotoxin; histone H3K9 methylation; histone methyltransferase (HMT); inhibitor; Suv39h1

Indexed keywords

11,11' DIDEOXYVERTICILLIN A; BACTERIAL PROTEIN; BISDETHIOBIS(METHYLTHIO)ACETYLGLIOTOXIN; CHETOMIN; GLIOTOXIN; H3K9 PROTEIN; HISTONE LYSINE METHYLTRANSFERASE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

EID: 84861607876     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2014.101     Document Type: Erratum

References (18)

1. Noma, K., Allis, C. D. & Grewal, S. I. Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries. Science 293, 1150-1155 (2001).
2. Tachibana, M., Sugimoto, K., Fukushima, T. & Shinkai, Y. Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 276, 25309-25317 (2001).
3. Rea, S. et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593-599 (2000).
4. Tachibana, M. et al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 19, 815-826 (2005).
5. Baylin, S. B. & Ohm, J. E. Epigenetic gene silencing in cancer - A mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107-116 (2006).
6. Cheng, X. & Blumenthal, R. M. Coordinated chromatin control: Structural and functional linkage of DNA and histone methylation. Biochemistry 49, 2999-3008 (2010).
7. Watanabe, H. et al. Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int. 8, 15 (2008).
8. Huang,J.et al. G9a and Glp methylate lysine 373 in the tumor suppressor p53. J. Biol. Chem. 285, 9636-9641 (2010).
9. Chen,M.W.et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 70, 7830-7840 (2010).
10. Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E. & Imhof, A. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat. Chem. Biol. 1, 143-145 (2005).
11. Kubicek, S. et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell 25, 473-481 (2007).
12. Chang, Y. et al. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nat. Struct. Mol. Biol. 16, 312-317 (2009).
13. Liu, F. et al. Discovery of a 2,4-diamino-7-Aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J. Med. Chem. 52, 7950-7953 (2009).
14. Liu, F. et al. Protein lysine methyltransferase G9a inhibitors: Design, synthesis, and structure activity relationships of 2,4-diamino-7-Aminoalkoxy- quinazolines. J. Med. Chem. 53, 5844-5857 (2010).
15. Vedadi, M. et al. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat. Chem. Biol. 7, 566-574 (2011).
16. Iwasa, E. et al. Total synthesis of (+)-chaetocin and its analogues: Their histone methyltransferase G9a inhibitory activity. J. Am. Chem. Soc. 132, 4078-4079 (2010).
17. Nishioka, K. et al. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 16, 479-489 (2002).
18. Gardiner, D. M., Waring, P. & Howlett, B. J. The epipolythiodioxopiperazine (ETP) class of fungal toxins: Distribution, mode of action, functions and biosynthesis. Microbiology 151, 1021-32 (2005).